Cancer Institute Hospital of JFCR ( Site 1000)

Tokyo 135-8550

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Renal Cell

Studies at this site

• A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005) — Running, not enrolling